This study aimed to evaluate the impact of preoperative anti-VEGF injections on pars plana vitrectomy (PPV) outcomes in patients with proliferative diabetic retinopathy (PDR). The gene discussed is VEGFA; the disease is proliferative diabetic retinopathy.